Health-related quality of life studies in clinical trials: Assessment of their methodological quality through a check-list;Estudios de calidad de vida relacionada con la salud incluidos en ensayos clínicos: valoración de su calidad metodológica mediante de una lista-guía

Medicina Clinica

Volumn 133, Issue 8, 2009, Pages 314-320

  Soto, Javier ^a   Rejas, Javier ^a   Ruiz, Miguel ^b   Pardo, Antonio ^b  

^a PFIZER INC   (United States)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHECKLIST; CLINICAL ASSESSMENT; CLINICAL RESEARCH; HUMAN; METHODOLOGY; QUALITY OF LIFE; REVIEW;

CHECKLIST; CONTROLLED CLINICAL TRIALS AS TOPIC; HEALTH STATUS; HUMANS; PSYCHOMETRICS; QUALITY OF LIFE; RESEARCH DESIGN;

EID: 68649122582     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2009.04.027     Document Type: Article

References (44)

1. J. Casa Anguita, J.R. Repullo Labrador, and J. Pereira Candal Medidas de calidad de vida relacionada con la salud. Conceptos básicos, construcción y adaptación cultural Med Clin (Barc) 116 2001 26 33
2. M.A. Testa, and D.C. Simonson Current concepts: Assessment of quality of life outcomes N Engl J Med 334 1996 835 840
3. D.F. Cella, I. Wiklund, S.A. Shumaker, and N.K. Aaronson Integrating health-related quality of life into cross-national clinical trials Qual Life Res 2 1993 433 440 (Pubitemid 24035215)
4. C.W. Lee, and K.N. Chi The standard of reporting of health-related quality of life in clinical cancer trials J Clin Epidemiol 53 2000 451 458
5. O. Chassany, J.F. Bergmann, and C. Caulin Reporting on quality of life in randomized controlled trials BMJ 38 1999 1142
6. L. Le Cleach, O. Chassany, A. Levy, P. Wolkenstein, and O. Chosidow Poor reporting of quality of life outcomes in dermatology randomized controlled clinical trials Dermatology 216 2008 46 55
7. R. Jaeschke, J. Singer, and G. Guyatt Measurement of health status: Ascertaining minimal clinically important difference Control Clin Trials 10 1989 407 415
8. T.M. Gill, and A.R. Feinstein A critical appraisal of the quality of quality of life instruments JAMA 272 1994 619 626
9. G.H. Guyatt, B. Kirshner, and R. Jaeschke Measuring health status: What are the necessary measurement properties? J Clin Epidemiol 45 1992 1341 1345
10. S.J. Coons, S. Rao, D.L. Keininger, and R.D. Hays A comparative review of generic quality of life questionnaires Pharmacoeconomics 17 2000 13 35
11. G.H. Guyatt, C. Bombadier, and P.X. Tugwell Measuring disease-specific quality of life in clinical trials Can Med Assoc J 134 1986 889 895
12. J. Dowie Decisión validity should determine whether a generic or condition-specific HRQOL measure is used in health care decisions Health Econ 11 2002 1 8
13. F. Guillemin, C. Bombardier, and D. Beaton Cross-cultural adaptation of health-related quality of life measures: Literature review and proposed guidelines J Clin Epidemiol 46 1993 1417 1432
14. C. Acquadro, K. Conway, A. Hareendran, N. Aaronson for the European Regulatory Issues and Quality of Life Assessment (ERIQA) Group Literature review of methods to translate health-related quality of life questionnaires for use in multinational clinical trials Value Health 11 2008 509 521
15. K.N. Lohr, N.K. Aaronson, J. Alonso, M.A. Burnam, D.L. Patrick, and E.B. Perrin Evaluating quality-of-life and health status instruments: Development of scientific review criteria Clin Ther 18 1996 979 992
16. M.A. Testa, and J.F. Nackley Methods for quality-of-life studies Ann Rev Public Health 15 1994 535 559
17. M. Bergner, and M.L. Rothman Health status measures: An overview and guide for selection Ann Rev Public Health 8 1987 191 210
18. P.M. Fayers, and D. Machin Quality of life: The assessment, analysis, and interpretation of patient-reported outcomes 2 ed 2007 Wiley Chichester, England
19. F. Bonnetain, X. Paoletti, S. Collette, M. Doffel, O. Bouché, and J.L. Raoul Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: Results from two French clinical trials Qual Life Res 17 2008 831 843
20. R.A. Deyo, P. Diehr, and D.L. Patrick Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation Control Clin Trials 12 1991 S142 S158
21. Spilker B. Quality of life trials. En: Spilker B, editor. Guide to clinical trials. New York, NY: Raven Press; 1991. p. 370-8.
22. Revicki D, Fairclough D. Preventing missing data. En: Fayers P, Hays R, editores. Assessing quality of life in clinical trials. 2 ed. New York: Oxford University Press; 2005;pp:167-78.
23. Lydick E, Epstein RS. Clinical significance of quality of life data. En: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. Philadelphia, PA: Lippincott-Raven Publishers; 1996. p. 461-5.
24. A. Fletcher Quality-of-life measurements in the evaluation of treatment: Proposed guidelines Br J Clin Pharmac 39 1995 217 222
25. L. Offerhaus Measurement of the quality of life in clinical trials: In pursuit of the unapproachable Eur J Clin Pharmacol 40 1991 205 208
26. A.E. Fletcher, B.M. Hunt, and C.J. Bulpitt Evaluation of quality of life in clinical trials in cardiovascular disease J Chron Dis 40 1987 557 566
27. C. Molin, and C. Arrigo Clinical trials and quality of life assessment: The nurses' viewpoint Eur J Cancer 31A 1995 S8 S10
28. I. Wiklund Practical issues in the design and inclusion of quality of life in multicenter clinical trials Br J Med Econ 6C 1993 45 48
29. M. Staquet, R. Berzon, D. Osoba, and D. Machin Guidelines for reporting results of quality of life assessments in clinical trials Qual Life Res 5 1996 496 502
30. Curran D, Fayers PM, Molenperghs G, Machin D. Analysis of incomplete quality of life data in clinical trials. En: Staquet MJ, Hays RD, Fayers PM, editores. Quality of life assessment in clinical trials. New York, NY: Oxford University Press; 1998. p. 249-80.
31. W.R. Myers Handling missing data in clinical trials: An overview Drug Inf J 34 2000 525 533
32. J.M. Engels, and P. Diehr Imputation of missing longitudinal data: A comparison of methods J Clin Epidemiol 56 2003 968 976
33. M. Schumaker, M. Olschewski, and G. Schulgen Assessment of quality of life in clinical trials Stat Med 10 1991 1915 1930
34. Osoba D, King M. Meaningful differences. En: Fayers P, Hays R, editores. Assessing quality of life in clinical trial. 2 ed. New York: Oxford University Press; 2005;pp:243-59.
35. G. Samsa, D. Edelman, M.L. Rothman, G.R. Williams, J. Lipscomb, and D. Matchar Determining clinically important differences in health status measures Pharmacoeconomics 15 1999 141 155
36. K.W. Wyrwich, W.M. Tierney, and F.D. Wolinsky Using the standard error of measurement to identify important changes on the asthma quality of life questionnaire Qual Life Res 11 2002 1 7
37. Rejas, M. Ruiz, and A. Pardo El error estándar de medida: ¿una alternativa a la diferencia mínimamente importante para evaluar cambios en las medidas de salud autopercibida? An Med Interna (Madrid) 24 2007 415 420
38. G. Guyatt, D. Osoba, A. Wu, K. Wyrwich, G.R. Norman the Clinical Significance Consensus Meeting group Methods to explain the clinical significance of health status measures Mayo Clin Proc 77 2002 371 383
39. R.J. Cook, and D.L. Sackett The number needed to treat: A clinically useful measure of treatment effect Br Med J 310 1995 452 454
40. E.F. Juniper, D.B. Price, P.A. Stampone, J. Creemers, S.J.M. Mol, and P. Fireman Clinically important improvements in asthma-specific quality of life, but no differences in patients changed from conventional beclomethasone dipropionate to approximately half the dose of extrafine beclomethasone dipropionate Chest 121 2002 1824 1832
41. R.D. Hays, and J.M. Woolley The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it? Pharmacoeconomics 18 2000 419 423
42. D.A. Revicki, A. Gnanesakthy, and K. Weinfurt Documenting the rationale and psychometric characteristics of patients reported outcomes for labelling and promotional claims: The PRO evidence dossier Qual Life Res 16 2007 717 723
43. US Department of Health and Human Services FDA Center for Drug Evaluation and Research; US Department of Health and Human Services FDA Center for Biologics Evaluation and Research; US Department of Health and Human Services FDA Center for Devices and radiological Health. Guidance for industry: Patient-reported outcome measures: Use in medical product development to support labelling claims: drfat guidance. Health Qual Life Outcomes. 2006;4:79 (doi:10.1186/1477-7525-4-79 )
44. EMEA/CHMP/EWP/139391/2004 Reflection paper on the regulatory guidance for the use of health related quality of life (HRQL) measures in the evaluation of medicinal products 2006 EMEA London